Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.72 |
| ▸ | MEN1 | O00255 | 2/20 | 0.72 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.72 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.72 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.56 |
| ▸ | POLB | P06746 | 2/20 | 0.56 |
| ▸ | GAA | P10253 | 2/20 | 0.56 |
| ▸ | TSHR | P16473 | 2/20 | 0.54 |
| ▸ | CDC25B | P30305 | 2/20 | 0.51 |
| ▸ | CA12 | O43570 | 3/20 | 0.50 |
| ▸ | CA1 | P00915 | 3/20 | 0.50 |
| ▸ | CA2 | P00918 | 3/20 | 0.50 |
| ▸ | CA7 | P43166 | 3/20 | 0.50 |
| ▸ | CA9 | Q16790 | 3/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.50 |
| ▸ | MAOB | P27338 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13301476 | 0.92 | L3MBTL1 (0.72) | SMN1; SMN2MEN1KMT2AL3MBTL1ALDH1A1 | |
| SCHEMBL13301485 | 0.90 | L3MBTL1 (0.69) | SMN1; SMN2MEN1KMT2AL3MBTL1ALDH1A1 | |
| SCHEMBL13301464 | 0.90 | L3MBTL1 (0.69) | SMN1; SMN2MEN1KMT2AL3MBTL1ALDH1A1 | |
| SCHEMBL27913467 | 0.89 | MEN1 (0.89) | SMN1; SMN2MEN1KMT2AL3MBTL1ALDH1A1 | |
| SCHEMBL13301475 | 0.89 | L3MBTL1 (0.67) | SMN1; SMN2MEN1KMT2AL3MBTL1ALDH1A1 | |
| SCHEMBL13301471 | 0.89 | L3MBTL1 (0.67) | SMN1; SMN2MEN1KMT2AL3MBTL1ALDH1A1 | |
| SCHEMBL13301457 | 0.89 | L3MBTL1 (0.67) | SMN1; SMN2MEN1KMT2AL3MBTL1ALDH1A1 | |
| SCHEMBL13301483 | 0.89 | SMN1; SMN2 (0.67) | SMN1; SMN2MEN1KMT2AL3MBTL1ALDH1A1 | |
| SCHEMBL13301467 | 0.89 | L3MBTL1 (0.67) | SMN1; SMN2MEN1KMT2AL3MBTL1ALDH1A1 | |
| SCHEMBL13301466 | 0.89 | SMN1; SMN2 (0.67) | SMN1; SMN2MEN1KMT2AL3MBTL1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4543872-A1 | MULTI-PHOTOPROTECTIVE COMPOUNDS AND USES THEREOF | SKINOSIVE (FR) | 2025-04-30 | — | — | EP | disclosed |
| WO-2023247598-A1 | MULTI-PHOTOPROTECTIVE COMPOUNDS AND USES THEREOF | SKINOSIVE (FR) | 2023-12-28 | — | — | WO | disclosed |
| US-10555892-B1 | Functionalized siloxane or polysiloxane coated particles with enhanced light filtering properties | NANOPHASE TECHNOLOGIES CORPORATION (US) | 2020-02-11 | — | — | US | disclosed |
| US-7988953-B2 | cosmetic; dendritic polyether; sunscreens | DSM IP ASSETS B.V. (NL) | 2011-08-02 | — | — | US | disclosed |
| US-20080081025-A1 | Uv Absorbing Chromophores Covalently Bonded to Hyperbranched Polymers | DSM IP ASSETS B.V. (NL) | 2008-04-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10555892-B1 | Functionalized siloxane or polysiloxane coated particles with enhanced light filtering properties | SPIN4, RPS4X, RPS4Y1 | SMN1; SMN2 599/4885MEN1 4144/4885KMT2A 2398/4885 |
| US-20080081025-A1 | Uv Absorbing Chromophores Covalently Bonded to Hyperbranched Polymers | PCNA, MMS19, ERCC4 | SMN1; SMN2 2132/4885MEN1 1481/4885KMT2A 1962/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.